ACTH Deficiency

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Sep 14, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity
Status:
Completed
Last Changed:
Jan 27, 2021
First Changed:
Sep 12, 2016
Disease(s):
Pro-opiomelanocortin (POMC) Deficiency Obesity
Intervention(s):
SetmelanotidePlacebo
RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients
Status:
Unknown status
Last Changed:
Feb 22, 2016
First Changed:
Jul 24, 2015
Disease(s):
Homozygous or Compound Heterozygous POMC, LEPR or PCSK1 Gene Mutation
Intervention(s):
RM-493
Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism
Status:
Unknown status
Last Changed:
Feb 23, 2017
First Changed:
Nov 4, 2014
Disease(s):
Adrenal Insufficiency
Intervention(s):
HydrocortisonePlenadren

Connect. Empower. Inspire.